Trends in FDA Adverse Events Reporting for InferiorVena Cava Filters and Estimated Insertions in the US,2016 to 2020 - Device Events | Improve Patient Outcomes & Reduce Risk Through Better Information.

IMPROVE OUTCOMES | REDUCE RISK

Trends in FDA Adverse Events Reporting for Inferior
Vena Cava Filters and Estimated Insertions in the US,
2016 to 2020

Date

01.25.23

To prevent potentially fatal pulmonary emboli, inferior vena cava filters (IVCFs) are implanted in patients with venous
thromboembolism and contraindications to anticoagulation. A systematic review and meta-analysis of 6 randomized clinical trials of IVCFs found slightly decreased rates of pulmonary embolism, increased rates of deep vein thrombosis, and no changes in mortality.

READ MORE